Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | IP-001 |
Synonyms | |
Therapy Description |
IP-001 is a carbohydrate biopolymer that acts as an immune stimulant, potentially increasing antitumor immunity (PMID: 33668932, PMID: 32042338, PMID: 35808806). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
IP-001 | N-dihydrogalactochitosan|IP001|IP 001 | IP-001 is a carbohydrate biopolymer that acts as an immune stimulant, potentially increasing antitumor immunity (PMID: 33668932, PMID: 32042338, PMID: 35808806). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05688280 | Phase Ib/II | IP-001 | Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS (INJECTABL-1) | Recruiting | USA | GBR | FRA | DEU | 1 |